FR496M - - Google Patents

Info

Publication number
FR496M
FR496M FR837268A FR837268A FR496M FR 496 M FR496 M FR 496M FR 837268 A FR837268 A FR 837268A FR 837268 A FR837268 A FR 837268A FR 496 M FR496 M FR 496M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837268A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR793714A external-priority patent/FR1292921A/fr
Application filed filed Critical
Priority to FR837268A priority Critical patent/FR496M/fr
Application granted granted Critical
Publication of FR496M publication Critical patent/FR496M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR837268A 1958-05-01 1960-08-30 Active FR496M (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837268A FR496M (ja) 1958-05-01 1960-08-30

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US732126A US2937284A (en) 1958-05-01 1958-05-01 2, 4-diamino-5, 6-dialkylpyrido (2, 3-d) pyrimidines and method
FR793714A FR1292921A (fr) 1959-05-30 1959-05-30 2.4-diamino-pyrido-(2.3)-pyrimidines et leur préparation
FR837268A FR496M (ja) 1958-05-01 1960-08-30

Publications (1)

Publication Number Publication Date
FR496M true FR496M (ja) 1961-05-08

Family

ID=24942307

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837268A Active FR496M (ja) 1958-05-01 1960-08-30

Country Status (4)

Country Link
US (1) US2937284A (ja)
CH (2) CH382177A (ja)
FR (1) FR496M (ja)
GB (1) GB913710A (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1225318B (de) * 1959-09-05 1966-09-22 Bayer Ag Verfahren zur Herstellung von Azofarbstoffen und deren Metallkomplexverbindungen
US3167537A (en) * 1959-09-05 1965-01-26 Bayer Ag Azo dyestuffs and their metal complex compounds
GB1088102A (en) * 1964-01-10 1967-10-25 Wellcome Found Halogen substituted pyrido-pyrimidines
US3225047A (en) * 1964-02-24 1965-12-21 Bristol Myers Co N,n'-bis(pyrimidine-5-acetyl)ethylene diamines
US3939268A (en) * 1971-04-10 1976-02-17 Boehringer Ingelheim Gmbh 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents
HU184787B (en) * 1979-06-14 1984-10-29 Wellcome Found Process for preparing alkoxy-benzyl-pyrido-pyrimidine derivatives
JPS5618982A (en) * 1979-06-14 1981-02-23 Wellcome Found Pyrimidine derivatives and medicinal drug containing them
US4959474A (en) * 1979-06-14 1990-09-25 Burroughs Wellcome Co. Dialkoxy pyridopyrimidine compounds
US4512992A (en) * 1980-06-13 1985-04-23 Burroughs Wellcome Co. Treatment with dialkoxy pyridopyrimidine compounds
AU598093B2 (en) * 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
GB8912336D0 (en) * 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds
MXPA06006777A (es) * 2003-12-16 2006-08-23 Pfizer Prod Inc Pirido[2,3-d]pirimidina-2,4-diaminas como inhibidores de fosfodiesterasas 2.
AU2008239596B2 (en) * 2007-04-11 2013-08-15 Exelixis, Inc. Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774095A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds

Also Published As

Publication number Publication date
CH382178A (de) 1964-09-30
CH382177A (de) 1964-09-30
US2937284A (en) 1960-05-17
GB913710A (en) 1962-12-28

Similar Documents

Publication Publication Date Title
FR496M (ja)
JPS3528622Y1 (ja)
IT604687A (ja)
AT214638B (ja)
JPS362785B1 (ja)
JPS373680B1 (ja)
AT221043B (ja)
AT217439B (ja)
AT215747B (ja)
JPS3820472Y1 (ja)
AT213316B (ja)
AT213908B (ja)
AT216227B (ja)
AT215751B (ja)
AT213446B (ja)
JPS364403B1 (ja)
AT216803B (ja)
AT213670B (ja)
AT214348B (ja)
AT214270B (ja)
AT216612B (ja)
AT216749B (ja)
AT216771B (ja)
FI43680B (ja)
AT216831B (ja)